FDA Lifts Major Warnings on Hormone Replacement Therapy
WEDNESDAY, Nov. 12, 2025 The U.S. Food and Drug Administration (FDA) is eliminating the prominent black box warnings on many hormone replacement therapy (HRT) m
With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
The planned trial targets adults with Stage 2-4 chronic kidney disease and will track kidney function and inflammation markers. Recruitment starts after listing. Post Views: 1